Literature DB >> 7840169

Insulin-mediated changes in PD and glucose uptake after correction of acidosis in humans with CRF.

D Reaich1, K A Graham, S M Channon, C Hetherington, C M Scrimgeour, R Wilkinson, T H Goodship.   

Abstract

To test the hypothesis that acidosis contributes to the insulin resistance of chronic renal failure (CRF) and impairs the action of insulin to decrease protein degradation, eight CRF patients were studied using the combined L-[1-13C]leucine-euglycemic clamp technique before (acid) and after (NaHCO3) 4 wk treatment with NaHCO3 (pH: acid 7.29 +/- 0.01 vs. NaHCO3 7.36 +/- 0.01, P < 0.001). Protein degradation (PD) was estimated sequentially from the kinetics of a primed continuous infusion of L-[1-13C]leucine in the basal state and during a hyperinsulinemic euglycemic clamp. Insulin sensitivity was measured during the clamp. The correction of acidosis significantly increased the glucose infusion rate necessary to maintain euglycemia (acid 6.44 +/- 0.89 vs. bicarbonate 7.38 +/- 0.90 mg.kg-1.min-1, P < 0.01) and significantly decreased PD in the basal state (acid 126.4 +/- 8.1 vs. bicarbonate 100.1 +/- 6.9 mumol.kg-1.h-1, P < 0.001). Hyperinsulinemia decreased PD in both studies (acid basal 126.4 +/- 8.1 vs. clamp 96.5 +/- 7.7, P < 0.001; bicarbonate basal 100.1 +/- 6.9 vs. clamp 88.2 +/- 5.5 mumol.kg-1.h-1, P = 0.06), its effect being unaltered by acidosis, with a reduction of 24% before and 12% after the correction of acidosis. In conclusion, acidosis contributes to the insulin resistance of CRF but does not affect the action of insulin on PD.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7840169     DOI: 10.1152/ajpendo.1995.268.1.E121

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  15 in total

Review 1.  Role of Acid-Base Homeostasis in Diabetic Kidney Disease.

Authors:  Pascale Khairallah; Julia J Scialla
Journal:  Curr Diab Rep       Date:  2017-04       Impact factor: 4.810

2.  Effects of Sodium Bicarbonate in CKD Stages 3 and 4: A Randomized, Placebo-Controlled, Multicenter Clinical Trial.

Authors:  Michal L Melamed; Edward J Horwitz; Mirela A Dobre; Matthew K Abramowitz; Liping Zhang; Yungtai Lo; William E Mitch; Thomas H Hostetter
Journal:  Am J Kidney Dis       Date:  2019-11-05       Impact factor: 8.860

Review 3.  Bicarbonate Balance and Prescription in ESRD.

Authors:  Matthew K Abramowitz
Journal:  J Am Soc Nephrol       Date:  2016-11-23       Impact factor: 10.121

4.  Plasma bicarbonate and risk of type 2 diabetes mellitus.

Authors:  Ernest I Mandel; Gary C Curhan; Frank B Hu; Eric N Taylor
Journal:  CMAJ       Date:  2012-07-23       Impact factor: 8.262

5.  Serum bicarbonate levels and the progression of kidney disease: a cohort study.

Authors:  Samir N Shah; Matthew Abramowitz; Thomas H Hostetter; Michal L Melamed
Journal:  Am J Kidney Dis       Date:  2009-04-25       Impact factor: 8.860

6.  Effects of oral sodium bicarbonate in patients with CKD.

Authors:  Matthew K Abramowitz; Michal L Melamed; Carolyn Bauer; Amanda C Raff; Thomas H Hostetter
Journal:  Clin J Am Soc Nephrol       Date:  2013-02-07       Impact factor: 8.237

7.  Inhibition of SNAT2 by metabolic acidosis enhances proteolysis in skeletal muscle.

Authors:  Kate Evans; Zeerak Nasim; Jeremy Brown; Emma Clapp; Amin Amin; Bin Yang; Terence P Herbert; Alan Bevington
Journal:  J Am Soc Nephrol       Date:  2008-07-23       Impact factor: 10.121

8.  Dietary Acid Load is Associated With Serum Bicarbonate but not Insulin Sensitivity in Chronic Kidney Disease.

Authors:  Halil O Ikizler; Leila Zelnick; John Ruzinski; Laura Curtin; Kristina M Utzschneider; Bryan Kestenbaum; Jonathan Himmelfarb; Ian H de Boer
Journal:  J Ren Nutr       Date:  2015-10-23       Impact factor: 3.655

9.  Insulin resistance and muscle metabolism in chronic kidney disease.

Authors:  James L Bailey
Journal:  ISRN Endocrinol       Date:  2013-02-03

10.  Does oral sodium bicarbonate therapy improve function and quality of life in older patients with chronic kidney disease and low-grade acidosis (the BiCARB trial)? Study protocol for a randomized controlled trial.

Authors:  Miles D Witham; Margaret M Band; Roberta C Littleford; Alison Avenell; Roy L Soiza; Marion E T McMurdo; Deepa Sumukadas; Simon A Ogston; Edmund J Lamb; Geeta Hampson; Paul McNamee
Journal:  Trials       Date:  2015-08-01       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.